Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

STT's $22.8m convertible bridge facility

11 Jan 2018 07:00

RNS Number : 5468B
Allied Minds PLC
11 January 2018
 

Update on Spin Transfer Technologies' $22.8 million convertible bridge facility

 

 

Boston MA - 11 January 2018 - Allied Minds (ALM: LSE) today announces that it has syndicated $10.28 million of the $22.8 million convertible bridge facility commitment it put in place for Spin Transfer Technologies (STT) in October 2017.

 

Existing STT shareholders Invesco Asset Management (Invesco) and Woodford Investment Management (WIM) will subscribe $10.28 million for convertible equity securities in STT, and Allied Minds commitment to the convertible bridge facility will be reduced by a corresponding amount to $12.52 million.

 

The facility is designed to bridge STT to the completion of a planned Series B funding round targeting strategic investors.

 

 

ENDS

 

For more information, please contact:

 

Allied Minds plc

Neil Pizey, Head of Corporate Development

+44 7771 872 922

FTI Consulting

Ben Atwell / Brett Pollard

+44 20 3727 1000

 

 

About Allied Minds

Based in Boston, Allied Minds plc is an IP commercialisation company focused on technology and life sciences. With extensive access to U.S. federal government laboratories and universities, as well as partnerships with leading U.S. corporations, Allied Minds forms, funds, and operates a portfolio of companies with the objective of delivering successful liquidity events that will generate attractive long-term returns for its investors and stakeholders. Allied Minds supports its businesses with capital, resources, and expertise.

For more information, please visit www.alliedminds.com

 

About STT

Spin Transfer Technologies, Inc. (STT) is seeking to develop ST-MRAM technologies that uniquely combine patented magnetics technologies, circuits and memory architectures to create the industry's lowest-cost, highest-performance ST-MRAM memories. STT's disruptive ST-MRAM solutions are ideal replacements for embedded and stand-alone SRAMs as well as future DRAM devices, affecting more than half of the $300+ billion semiconductor industry. The company was established by Allied Minds and New York University. For more information, please visit www.spintransfer.com.

 

Further information on the fund-raise

Of the $10.28 million STT convertible equity securities subscribed, Invesco contributed $6.0 million for the purchase of 600 securities and WIM contributed $4.28 million for the purchase of 428 securities Both Invesco and WIM are substantial shareholders of Allied Minds pursuant to the Listing Rules and thus, this transaction is a smaller related party transaction falling within the scope of Listing Rule 11.1.10R.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKKDKFBKDBDD
Date   Source Headline
7th Dec 201812:02 pmRNSPrice Monitoring Extension
6th Dec 201812:02 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSHawkEye 360 successful pathfinder satellite launch
12th Nov 20187:00 amRNSSpin Memory series B and commercial partnerships
9th Nov 20185:09 pmRNSBlocklisting Six Monthly Return
9th Nov 20185:05 pmRNSBlocklisting Six Monthly Return
27th Sep 20187:00 amRNSHalf-year Report
24th Sep 20187:00 amRNSSTT announces appointment of Chairman
18th Sep 20187:00 amRNSAllied Minds forms QuayChain subsidiary
10th Sep 20187:00 amRNSHawkEye 360 completes second Series A-3 funding
10th Sep 20187:00 amRNSBridgeSat raises $10.0 million Series B financing
10th Sep 20187:00 amRNSFederated Wireless update
15th Aug 20184:35 pmRNSPrice Monitoring Extension
13th Aug 20187:03 amRNSNotice of Results
13th Aug 20187:00 amRNSHawkEye 360 raises $9.6m in Series A-3 financing
11th Jul 20184:35 pmRNSPrice Monitoring Extension
11th Jul 20187:00 amRNSPrecision Biopsy appoints Chief Operating Officer
2nd Jul 20183:15 pmRNSTotal Voting Rights
26th Jun 20185:17 pmRNSDirector/PDMR Shareholding
19th Jun 20184:54 pmRNSDirector/PDMR Shareholding
19th Jun 20184:48 pmRNSDirector/PDMR Shareholding
19th Jun 20184:38 pmRNSDirector/PDMR Shareholding
12th Jun 201811:12 amRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSDirectorate Change
23rd May 20183:30 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading Statement
16th May 20181:25 pmRNSDirector/PDMR Shareholding
16th May 201811:24 amRNSDirector/PDMR Shareholding
16th May 201810:51 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSFederated Wireless Update
11th May 20189:38 amRNSBlocklisting Six Monthly Return
11th May 20189:31 amRNSBlocklisting Six Monthly Return
1st May 20183:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSAllied Minds leads funding round at TableUp
9th Apr 20188:25 amRNSAllied Minds leads Orbital Sidekick funding round
6th Apr 20187:00 amRNSNotice of AGM and Annual Report
3rd Apr 201811:26 amRNSTotal Voting Rights
22nd Mar 20187:01 amRNSDirectorate Change
22nd Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20187:00 amRNSNotice of Results
1st Mar 20182:17 pmRNSTotal Voting Rights
1st Feb 201810:20 amRNSTotal Voting Rights
22nd Jan 20183:25 pmRNSDirector/PDMR Shareholding
22nd Jan 20183:22 pmRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSCapital Markets Day Materials
17th Jan 20187:00 amRNSAllied Minds: Sale of Percipient Networks
11th Jan 20187:00 amRNSSTT's $22.8m convertible bridge facility
19th Dec 201712:02 pmRNSPrice Monitoring Extension
18th Dec 20177:00 amRNSSciFluor: results of phase 1/2 study of SF0166
30th Nov 201712:12 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.